Does OCRELIZUMAB Cause Nasopharyngitis? 2,479 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,479 reports of Nasopharyngitis have been filed in association with OCRELIZUMAB (OCREVUS). This represents 4.4% of all adverse event reports for OCRELIZUMAB.
2,479
Reports of Nasopharyngitis with OCRELIZUMAB
4.4%
of all OCRELIZUMAB reports
7
Deaths
441
Hospitalizations
How Dangerous Is Nasopharyngitis From OCRELIZUMAB?
Of the 2,479 reports, 7 (0.3%) resulted in death, 441 (17.8%) required hospitalization, and 5 (0.2%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 2,479 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
Multiple sclerosis relapse (2,326)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which OCRELIZUMAB Alternatives Have Lower Nasopharyngitis Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE